000 | 01026 a2200265 4500 | ||
---|---|---|---|
005 | 20250515181657.0 | ||
264 | 0 | _c20091023 | |
008 | 200910s 0 0 eng d | ||
022 | _a1759-5037 | ||
024 | 7 |
_a10.1038/nrendo.2009.151 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJacobson, Terry A | |
245 | 0 | 0 |
_aMyopathy with statin-fibrate combination therapy: clinical considerations. _h[electronic resource] |
260 |
_bNature reviews. Endocrinology _cSep 2009 |
||
300 |
_a507-18 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aClofibric Acid _xadverse effects |
650 | 0 | 4 |
_aFenofibrate _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
650 | 0 | 4 |
_aHypolipidemic Agents _xadverse effects |
773 | 0 |
_tNature reviews. Endocrinology _gvol. 5 _gno. 9 _gp. 507-18 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrendo.2009.151 _zAvailable from publisher's website |
999 |
_c19044427 _d19044427 |